US › Healthcare

OUTLOOK THERAPEUTICS INC (OTLK)

US · Healthcare · Biotechnology

$0.68+0.61%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$9,000

Revenue YoY

-99.4%

Net profit

$-20.3M

EPS

$-0.09

EPS estimate

$-0.09

Net margin

-225,766.7%

EPS came in at -0.09 against a street estimate of -0.09 — a beat of 0.0%.

Key statistics

Market cap

$160.5M

Forward P/E

2.8

P/B

38.42

Book value

$-0.06

EPS (TTM)

$-0.72

52-week high

$2.54

52-week low

$0.16

50-day MA

$1.06

200-day MA

$0.85

Beta

0.75

Analyst view

Analysts rate OUTLOOK THERAPEUTICS INC a strong buy (5 buy, 1 hold, 0 sell out of 6) with an average price target of $4.90.

Shareholding

Insiders

12.64%

Institutions

16.67%

Largest institutional holders

Fund	Stake
Armistice Capital, LLC	2.60%
Vanguard Capital Management, LLC	1.23%
Geode Capital Management, LLC	0.38%
GILPIN WEALTH MANAGEMENT, LLC	0.35%
BlackRock Inc	0.30%
Renaissance Technologies Corp	0.16%
Nine Masts Capital Limited	0.15%
Vanguard Fiduciary Trust Co	0.11%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for OUTLOOK THERAPEUTICS INC — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.